Vor Biopharma Inc. Shares Outstanding
Vor Biopharma Inc. (VOR) had Shares Outstanding of 54.46 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-11
- 2026-06-30: Shares outstanding (split-adjusted) 54.46M shares; Shares authorized (split-adjusted) 800.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 54.19M shares; Shares authorized (split-adjusted) 800.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 38.72M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 9.03M shares; Shares authorized (split-adjusted) 800.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 54.46M shares 10-Q · filed 2026-08-11 | 800.00M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 54.19M shares 10-Q · filed 2026-05-13 | 800.00M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 38.72M shares 10-Q · filed 2026-08-11 | 400.00M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 9.03M shares 10-Q · filed 2025-11-13 | 800.00M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 125.65M shares 10-Q · filed 2025-08-12 | 800.00M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 124.85M shares 10-Q · filed 2025-05-14 | 400.00M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 6.24M shares 10-K · filed 2026-03-30 | 400.00M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 68.66M shares 10-Q · filed 2024-11-07 | 400.00M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 68.36M shares 10-Q · filed 2024-08-08 | 400.00M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 68.22M shares 10-Q · filed 2024-05-09 | 400.00M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 67.89M shares 10-K · filed 2025-03-20 | 400.00M shares 10-K · filed 2025-03-20 |
| 2023-09-30 | 67.79M shares 10-Q · filed 2023-11-07 | 400.00M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 67.43M shares 10-Q · filed 2023-08-10 | 400.00M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 66.93M shares 10-Q · filed 2023-05-11 | 400.00M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 66.00M shares 10-K · filed 2024-03-20 | 400.00M shares 10-K · filed 2024-03-20 |
| 2022-09-30 | 38.39M shares 10-Q · filed 2022-11-10 | 400.00M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 37.51M shares 10-Q · filed 2022-08-11 | 400.00M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 37.34M shares 10-Q · filed 2022-05-12 | 400.00M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 37.17M shares 10-K · filed 2023-03-23 | 400.00M shares 10-K · filed 2023-03-23 |
| 2021-09-30 | 37.02M shares 10-Q · filed 2021-11-10 | 400.00M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 36.89M shares 10-Q · filed 2021-08-09 | 400.00M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 36.77M shares 10-Q · filed 2021-05-06 | 400.00M shares 10-Q · filed 2021-05-06 |
| 2021-02-09 | (m) | 400.00M shares 10-Q · filed 2021-11-10 |
| 2020-12-31 | 505.07K shares 10-K · filed 2022-03-14 | 420.00M shares 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |